Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

Peter J. Cook(Memorial Sloan Kettering Cancer Center), Andrea Ventura(Memorial Sloan Kettering Cancer Center)
Nature Communications
July 11, 2017
Cited by 71


Related Papers